Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single-center Blinded Crossover Study Investigating the Efficacy of Apixaban in Patients with Painful Venous Malformations with Localized Intravascular Coagulation

NCT06729034 is registered in ClinicalTrials.gov with Oslo University Hospital as lead sponsor.

NCT NCT06729034
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06729034 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single-center Blinded Crossover Study Investigating the Efficacy of Apixaban in Patients with Painful Venous Malformations with Localized Intravascular Coagulation
Lead sponsor
Oslo University Hospital
Phase
Phase 2
Overall status
Not yet recruiting
Start date
February 1, 2025
Completion date
December 31, 2031
Enrollment
20 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anticoagulants, venous malformation, low flow